Asperger's Disorder Clinical Trial
Official title:
The Multi-media Social Skills Project: Validation of an Intervention for Adolescents With Autism Spectrum Disorders
This study is a pre-test, post-test single group design with follow-up at month three. Twenty-four individuals total will participate in this study with 6 participants in each of 4 cohorts. Participants and their parents will complete pre-test measures including both paper and pencil measures and a video-recording to assess the participant's social interaction skills and fluency. These adolescents will participate in both group therapy and peer generalization sessions once a week over the course of twelve weeks. Upon completion of the intervention, participants and parents will complete paper and pencil and video post-test measures. Participants will be encouraged to participate in one follow-up session where the paper and pencil and video measures will be completed again.
After consent , has been obtained, parents will complete the Autism Disorders
Interview-Revised (ADI-R; Rutter & LeCourteur, 1995) to determine eligibility and the
Checklist for Autism Spectrum Disorder (Mayes & Calhoun, 1999), the Social Responsiveness
Scale (SRS; Constantino, 2002), and the Strengths and Difficulties Questionnaire (SDQ;
Goodman, 1997) at the initial appointment with the study coordinator.
After assent has been obtained, adolescents will complete the Kaufman Brief Intelligence
Test, Second Edition (KBIT-2; Kaufman & Kaufman, 1990) to determine eligibility and the
Checklist for Autism Spectrum Disorder (Mayes & Calhoun, 1999), the Strengths and
Difficulties Questionnaire (SDQ; Goodman, 1997) and the Loneliness Scale (Asher & Wheeler,
1985). Adolescents will also complete a standardized joint attention assessment.
After the completion of the eligibility and pre-test interventions there will be a wash of
participants who do not meet eligibility requirements.
One week before the start of the program, participants will attend an introduction session to
the program. At this time, participants will be filmed in a brief interaction with a
typically developing peer that will be used as a baseline indicator of their social fluency.
Participants will attend the social skills intervention program once a week for twelve weeks.
Each week there will be approximately 90 minutes of group therapy which will be conducted
like a seminar class: the principal investigator will teach and review social interaction
skills and nuances, participants will be encouraged to take an active role in the class.
During the twelve week intervention there will be three review/fluency building sessions:
week four, week eight, and week twelve. The group therapy sessions for these review weeks
will simply review the material that was covered during the prior three weeks. Participants
will then practice what they have learned by having a conversation with a peer that will be
taped.
Following the group therapy session each week, participants will join six typically
developing peers in a 90 minute introductory photography class taught by one of the study's
co-investigators. The photography class will give the participants the opportunity to
practice the skills learned in group therapy with their peer group.
Participants will once again complete a battery of clinical and self-report outcome measures
which will serve as the post-test measurements for the study. They will be filmed in a brief
interaction with a typically developing peer which will be coded to obtain post-test social
interaction skills and fluency scores. These evaluations will occur at completion of social
skills program, and at three month follow-up.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01592747 -
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
|
Phase 2 | |
Withdrawn |
NCT00376194 -
Mercury Chelation to Treat Autism
|
Phase 2 | |
Terminated |
NCT01592773 -
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
|
Phase 2 | |
Enrolling by invitation |
NCT01078844 -
Memantine in Adult Autism Spectrum Disorder
|
N/A | |
Completed |
NCT00844753 -
Atomoxetine, Placebo and Parent Management Training in Autism
|
Phase 4 | |
Completed |
NCT00352196 -
Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study
|
Phase 4 | |
Completed |
NCT01631851 -
Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder
|
N/A | |
Completed |
NCT01086475 -
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
|
Phase 3 | |
Active, not recruiting |
NCT02199925 -
An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
|
Phase 4 | |
Completed |
NCT01592786 -
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
|
Phase 2 | |
Completed |
NCT01808066 -
GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs
|
N/A | |
Completed |
NCT00198055 -
A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
|
Phase 2 | |
Active, not recruiting |
NCT01031407 -
Cognitive Neuroscience of Autism Spectrum Disorders
|
||
Completed |
NCT00308074 -
An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders
|
Phase 2 | |
Completed |
NCT00808782 -
The Use of rTMS to Improve Theory of Mind Among Adults With Autism and Asperger's Disorder
|
N/A |